col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


21 Results       Page 1

 [1] 
Elsevier: Journal of Substance Use and Addiction Treatment
  original article Date Title Authors   All Authors
1 [GO] 2026―Feb―24 A longitudinal analysis of overall and telehealth addiction treatment utilization three years after pandemic-related policy changes Subarna Bhattacharya, Vanessa A. Palzes, Monique B. Does, Ninad R. Athale, Cynthia I. Campbell
2 [GO] 2025―Sep―11 Post-overdose outreach programs in Massachusetts before and after the onset of the COVID-19 pandemic Alexander Y. Walley, Jiayi Wang, C. To, MaryKate Duska, Stephen Murray, Moriah Wiggins, et al. (+7)
3 [GO] 2024―Dec―30 Description of implementing a mail-based overdose education and naloxone distribution program in community supervision settings during COVID-19 Carrie B. Oser, Margaret McGladrey, Douglas R. Oyler, Hannah K. Knudsen, Sharon L. Walsh, Susannah Stitzer, et al. (+6)
4 [GO] 2024―Oct―06 Was receipt of any specialty alcohol treatment during the pandemic effective at reducing drinking for patients with or at risk of AUD? Andrea H. Kline-Simon, Vanessa A. Palzes, Felicia W. Chi, Derek D. Satre, Constance Weisner, Stacy Sterling
5 [GO] 2024―Aug―07 Methadone treatment utilization and overdose trends among Medicaid beneficiaries in New Jersey before and during the COVID-19 pandemic James Lloyd, Peter Treitler, Jamey J. Lister, Molly Nowels, Stephen Crystal
6 [GO] 2024―May―12 Utilization of long-acting injectable monthly depot buprenorphine for opioid use disorder (OUD) in Kentucky, before and after COVID-19 related buprenorphine access policy changes Lindsey R. Hammerslag, Jeffery Talbert, Svetla Slavova, Feitong Lei, Patricia R. Freeman, Katherine R. Marks, et al. (+3)
7 [GO] 2024―Apr―25 Buprenorphine prescribing and treatment accessibility in response to regulation changes due to the COVID-19 public health emergency Taylor J. Paiva, Rachel S. Wightman, Kristen St. John, Adam Z. Nitenson, Collette Onyejekwe, Benjamin D. Hallowell
8 [GO] 2024―Mar―21 Critical incidents in Colorado's opioid treatment programs: A comparison of the COVID-19 pandemic to previous years Cole Bortz, Isaac Armistead, Angela Bonaguidi, D. Tyler Coyle
9 [GO] 2023―Dec―21 Family treatment courts and the COVID-19 pandemic: Barriers and facilitators to program implementation, client engagement, and recovery Danielle M. Romain Dagenhardt, Xiayo Liu, Jayden Richards, Joshua Mersky
10 [GO] 2023―Dec―05 Loss, liberation, and agency: Patient experiences of methadone treatment at opioid treatment programs during the COVID-19 pandemic Teresa López-Castro, Andrea Jakubowski, Mariya Masyukova, Meghan Peterson, Amanda Pierz, Sruthi Kodali, et al. (+3)
11 [GO] 2023―Nov―30 State guidance and system changes related to COVID-19: Impact on opioid treatment programs Douglas B. Fuller, Jan Gryczynski, Robert P. Schwartz, Caroline Halsted, Shannon Gwin Mitchell, Melanie Whitter
12 [GO] 2023―Oct―20 Gender differences in utilization of behavioral therapy and medication for opioid use disorder during the pandemic: A retrospective veteran cohort study Nicholas A. Livingston, Alexis Sarpong, Rebecca Sistad, Clara Roth, Anne N. Banducci, Tracy Simpson, et al. (+3)
13 [GO] 2023―Sep―18 COVID-19-related flexibility in methadone take-home doses associated with decreased attrition: Report from an opioid treatment program in central Pennsylvania Sarah S. Kawasaki, Rachel Zimmerman, Chan Shen, Aleksandra E. Zgierska
14 [GO] 2023―Aug―30 What can we learn from COVID-19 to improve opioid treatment? Expert providers respond Lesley M. Harris, Jeanne C. Marsh, Tenie Khachikian, Veronica Serrett, Yinfei Kong, Erick G. Guerrero
15 [GO] 2023―Jun―11 The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose Elias M. Klemperer, Laura Wreschnig, Abigail Crocker, Jessica King-Mohr, Annie Ramniceanu, John Brooklyn, et al. (+3)
16 [GO] 2023―Jun―01 Changes to methadone maintenance therapy in the United States, Canada, and Australia during the COVID-19 pandemic: A narrative review Victoria Panwala, Paul Joudrey, Melanie Kowalski, Paxton Bach, Ofer Amram
17 [GO] 2023―May―08 Impact of VA's video telehealth tablets on substance use disorder care during the COVID-19 pandemic Kritee Gujral, James Van Campen, Josephine Jacobs, Rachel Kimerling, Donna M. Zulman, Daniel Blonigen
18 [GO] 2023―Mar―31 Impact of changes to the delivery of opioid agonist treatment, introduced during the COVID-19 pandemic, on treatment access and dropout in Ireland: An interrupted time series analysis Louise Durand, Fiona Boland, Norma Harnedy, Íde Delargy, Mike Scully, Margaret Bourke, et al. (+4)
19 [GO] 2023―Mar―31 Predictors of opioid overdose during the COVID-19 pandemic: The role of relapse, treatment access and nonprescribed buprenorphine/naloxone Anna Kline, Jill M. Williams, Marc L. Steinberg, Dina Mattern, Megan Chesin, Suzanne Borys, Vamsee Chaguturu
20 [GO] 2023―Mar―17 Factors associated with problematic substance use before and during the COVID-19 pandemic among a drug addiction recovery cohort: A prospective study in the Netherlands, Belgium, and UK Thomas F. Martinelli, Gera E. Nagelhout, David Best, Wouter Vanderplasschen, Dike van de Mheen
21 [GO] 2023―Jan―07 Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore Tolulope M. Abidogun, Thomas O. Cole, Ebonie Massey, Mary Kleinman, Aaron D. Greenblatt, C.J. Seitz-Brown, et al. (+2)
 [1] 

21 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.003 sec